Abingdon Health Plc
ABDXF · OTC
6/30/2024 | 6/30/2023 | 6/30/2022 | 6/30/2021 | |
|---|---|---|---|---|
| Revenue | $6 | $4 | $3 | $12 |
| % Growth | 51.7% | 42.7% | -75.6% | – |
| Cost of Goods Sold | $2 | $2 | $8 | $8 |
| Gross Profit | $4 | $2 | -$5 | $3 |
| % Margin | 60% | 51.3% | -184.4% | 29.2% |
| R&D Expenses | $0 | $0 | $0 | $1 |
| G&A Expenses | $5 | $5 | $7 | $8 |
| SG&A Expenses | $5 | $5 | $7 | $8 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $1 |
| Other Operating Expenses | -$0 | $0 | $0 | $0 |
| Operating Expenses | $5 | $5 | $7 | $9 |
| Operating Income | -$1 | -$4 | -$12 | -$6 |
| % Margin | -22.4% | -88.7% | -427% | -47.5% |
| Other Income/Exp. Net | -$0 | $0 | -$0 | -$0 |
| Pre-Tax Income | -$1 | -$4 | -$22 | -$7 |
| Tax Expense | -$0 | -$0 | -$0 | -$0 |
| Net Income | -$1 | -$3 | -$21 | -$7 |
| % Margin | -20.7% | -85.8% | -750% | -60% |
| EPS | -0.004 | -0.011 | -0.073 | -0.073 |
| % Growth | 63.2% | 84.4% | -0.4% | – |
| EPS Diluted | -0.004 | -0.011 | -0.073 | -0.073 |
| Weighted Avg Shares Out | 303 | 304 | 292 | 96 |
| Weighted Avg Shares Out Dil | 305 | 304 | 292 | 96 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $1 | $1 | $9 |
| EBITDA | -$1 | -$3 | -$20 | -$5 |
| % Margin | -14.9% | -78.4% | -701.5% | -41.1% |